ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Vizient Announces Expansion of Novaplus Enhanced Supply in Med/Surg, Pharmacy

New categories support supply assurance for Vizient members

Vizient, Inc. today announced it has expanded Novaplus® Enhanced Supply to include three new medical/surgical categories and an antidotes category for pharmaceutical supplies. The new med/surg categories are durable medical equipment, sterile inhalation water and non-invasive ventilation. The antidotes category has 60 unique drugs, with 14 products already added to the program.

Through Novaplus Enhanced Supply (NES), Vizient provides supply assurance for participating Vizient members through increased inventory commitment from suppliers. The program expansion comes at a time of continued supply disruptions from the fallout of the pandemic and unpredictable geopolitical activity, and it focuses on a critical supply list driven by Vizient member hospitals.

“We are continually communicating with our members and contracted suppliers to prepare for and mitigate against potential supply disruptions,” said Margaret Steele, senior vice president of med/surg for Vizient. “It’s part of a strategy Vizient began before the pandemic that we have since accelerated to ensure hospitals have the supplies and medications they need to continue delivering patient care.”

With the new additions, the total number of med/ surg categories in the program is now 10, including durable medical equipment for the supply of crutches, sterile inhalation water used in respiratory procedures and non-invasive ventilation, which ventilates patients without using intubation.

In addition, Vizient has added the category of antidotes to its essential medications list, to include an additional 67 line items representing 60 unique drugs. It’s the second category on the essential medications list, and it serves to distinguish medications used in everyday care from those required in rarer instances to neutralize the effect of poison. The essential medications list helps to inform what drugs are included in NES, with 35% of everyday care drugs in the program and 21% of antidotes in the program to date.

Launched in 2019 to help secure the supply of essential medications and mitigate their potential shortages, Novaplus Enhanced Supply has since expanded to include personal protective equipment and other critical medical supplies. Novaplus Enhanced Supply supports a more resilient supply chain through transparency, accountability and commitment to supply.

About Vizient, Inc.

Vizient, Inc., the nation’s largest health care performance improvement company, serves more than 50% of the nation’s acute care providers, which includes 97% of the nation’s academic medical centers, and more than 20% of ambulatory care providers. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $130 billion in annual purchasing volume. Vizient’s solutions and services improve the delivery of high-value care by aligning cost, quality and market performance. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.

About Vizient Novaplus and Novaplus Enhanced Supply

The private label of Vizient®, Novaplus® consistently delivers cost savings on quality medical and pharmaceutical products from well-known manufacturers. Acute and nonacute providers who choose Novaplus also enjoy improved access, price protection, dedicated support and increased efficiency. Novaplus is a critical strategy in protecting Vizient health system and hospital members from supply disruptions that can adversely affect the delivery of quality patient care.

Contracted suppliers participating in Novaplus Enhanced Supply provide additional inventory of essential products to mitigate supply disruptions and demand surge. Contract terms provide greater predictability and sustainability to drive continued production and supply resiliency. Production transparency requirements increase visibility to anticipate and further mitigate potential supply disruptions. By purchasing through Novaplus Enhanced Supply, health care facilities also receive expanded value and benefits built on the foundation of the industry’s longest-run private label program.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.